![C. Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
C. Davis
Amministratore Delegato presso Angelica Therapeutics, Inc.
Posizioni attive di C. Davis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Angelica Therapeutics, Inc. | Amministratore Delegato | - | - |
Presidente | - | - | |
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Corporate Officer/Principal | 08/12/2009 | - |
Moerae Matrix, Inc. | Direttore/Membro del Consiglio | 30/04/2010 | - |
Moerae Matrix, Inc. /Nj/
![]() Moerae Matrix, Inc. /Nj/ Miscellaneous Commercial ServicesCommercial Services Moerae Matrix, Inc. is a biotechnology company based in Morristown, NJ. Moerae Matrix, Inc. develops novel therapies as a biotechnology company. The company was founded by Cynthia Lander, who has been the CEO since incorporation. | Direttore/Membro del Consiglio | 01/01/2010 | - |
Storia della carriera di C. Davis
Precedenti posizioni note di C. Davis
Società | Posizione | Inizio | Fine |
---|---|---|---|
STANDARD DIVERSIFIED INC | Direttore/Membro del Consiglio | 03/09/2007 | 23/07/2013 |
Independent Dir/Board Member | 03/09/2007 | 23/07/2013 | |
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - | - |
REPLIGEN CORPORATION | Corporate Officer/Principal | - | - |
Presidio Partners
![]() Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Direttore/Membro del Consiglio | - | - |
Abgenix, Inc.
![]() Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/1996 | - |
Fondatore | 05/08/2009 | - |
Formazione di C. Davis
Swarthmore College | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
REPLIGEN CORPORATION | Health Technology |
Aziende private | 8 |
---|---|
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Standard Diversified, Inc.
![]() Standard Diversified, Inc. TobaccoConsumer Non-Durables Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY. | Consumer Non-Durables |
Abgenix, Inc.
![]() Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Presidio Partners
![]() Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Finance |
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
Moerae Matrix, Inc. | |
Moerae Matrix, Inc. /Nj/
![]() Moerae Matrix, Inc. /Nj/ Miscellaneous Commercial ServicesCommercial Services Moerae Matrix, Inc. is a biotechnology company based in Morristown, NJ. Moerae Matrix, Inc. develops novel therapies as a biotechnology company. The company was founded by Cynthia Lander, who has been the CEO since incorporation. | Commercial Services |
Angelica Therapeutics, Inc. |
- Borsa valori
- Insiders
- C. Davis
- Esperienza